SEC Form 4 · accession 0001123292-17-001761
ARADIGM CORP · ARDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Juergen Kurt Froehlich
Officer — Chief Medical Officer
Period of report
Dec 6, 2017
Accepted (ET)
Dec 8, 2017 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013238
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.02 | Dec 6, 2017 | A | 50,000 | A | — | Dec 6, 2027 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Stock option vests in equal quarterly installments over four years, commencing on December 6, 2017.